HK1070669A1 - Growth hormone fusion protein - Google Patents
Growth hormone fusion proteinInfo
- Publication number
- HK1070669A1 HK1070669A1 HK05100765.8A HK05100765A HK1070669A1 HK 1070669 A1 HK1070669 A1 HK 1070669A1 HK 05100765 A HK05100765 A HK 05100765A HK 1070669 A1 HK1070669 A1 HK 1070669A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- growth hormone
- fusion protein
- hormone fusion
- modified
- binding domain
- Prior art date
Links
- 102000018997 Growth Hormone Human genes 0.000 title abstract 3
- 108010051696 Growth Hormone Proteins 0.000 title abstract 3
- 239000000122 growth hormone Substances 0.000 title abstract 3
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037865 fusion proteins Human genes 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 102100020948 Growth hormone receptor Human genes 0.000 abstract 1
- 108010068542 Somatotropin Receptors Proteins 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/61—Growth hormone [GH], i.e. somatotropin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/32—Fusion polypeptide fusions with soluble part of a cell surface receptor, "decoy receptors"
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Biochemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Vascular Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Emergency Medicine (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0130052A GB2384001B (en) | 2001-12-14 | 2001-12-14 | Chimeric growth hormone-growth hormone receptor proteins |
PCT/GB2002/005523 WO2003070765A2 (en) | 2001-12-14 | 2002-12-06 | Growth hormone fusion protein |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1070669A1 true HK1070669A1 (en) | 2005-06-24 |
Family
ID=9927705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK05100765.8A HK1070669A1 (en) | 2001-12-14 | 2005-01-28 | Growth hormone fusion protein |
Country Status (20)
Country | Link |
---|---|
US (2) | US7524649B2 (de) |
EP (2) | EP2365085A1 (de) |
JP (2) | JP5248734B2 (de) |
KR (3) | KR100879553B1 (de) |
CN (2) | CN101638437A (de) |
AT (1) | ATE541935T1 (de) |
AU (1) | AU2002366325B2 (de) |
CA (1) | CA2468439A1 (de) |
ES (1) | ES2378424T3 (de) |
GB (2) | GB2389115B (de) |
HK (1) | HK1070669A1 (de) |
HU (1) | HUP0402496A3 (de) |
IL (3) | IL162433A0 (de) |
MX (1) | MXPA04005675A (de) |
NZ (1) | NZ533550A (de) |
PL (1) | PL210714B1 (de) |
RU (2) | RU2346047C2 (de) |
SG (1) | SG160205A1 (de) |
WO (1) | WO2003070765A2 (de) |
ZA (2) | ZA200404488B (de) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2001274234A1 (en) * | 2000-06-16 | 2001-12-24 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
GB2389115B (en) * | 2001-12-14 | 2005-03-16 | Asterion Ltd | Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone |
DE60332358D1 (de) * | 2002-09-09 | 2010-06-10 | Hanall Pharmaceutical Co Ltd | Protease-resistente modifizierte interferon alpha polypeptide |
MX2007001180A (es) * | 2004-07-26 | 2007-04-13 | Asterion Ltd | Enlazantes. |
US7998930B2 (en) * | 2004-11-04 | 2011-08-16 | Hanall Biopharma Co., Ltd. | Modified growth hormones |
GB0606946D0 (en) * | 2006-04-06 | 2006-05-17 | Asterion Ltd | Polypeptide antagonist |
GB0618082D0 (en) * | 2006-09-14 | 2006-10-25 | Asterion Ltd | Growth factor |
US20080260820A1 (en) * | 2007-04-19 | 2008-10-23 | Gilles Borrelly | Oral dosage formulations of protease-resistant polypeptides |
GB0717985D0 (en) * | 2007-07-20 | 2007-10-24 | Asterion Ltd | Growth hormone fusion proteins |
GB0719818D0 (en) * | 2007-10-11 | 2007-11-21 | Asterion Ltd | Growth hormone fusion polypeptides |
WO2009077731A2 (en) * | 2007-12-19 | 2009-06-25 | Asterion Limited | Prolactin fusion proteins |
WO2011085070A2 (en) * | 2010-01-06 | 2011-07-14 | Virginia Tech Intellectual Properties, Inc. | Methods and compositions to improve the health of plants, animals and microbes by manipulating protein entry into symbionts and their hosts |
JP5412323B2 (ja) | 2010-02-26 | 2014-02-12 | 日東電工株式会社 | 貼付製剤 |
GB201104285D0 (en) * | 2011-03-15 | 2011-04-27 | Asterion Ltd | Modified receptor fusion proteins |
EP2606908A1 (de) | 2011-12-19 | 2013-06-26 | Ipsen Pharma S.A.S. | Neuartige pharmazeutische Zusammensetzung für ein lang wirkendes Wachstumshormonfusionsprotein (LAGH) |
US9717778B2 (en) | 2012-02-03 | 2017-08-01 | Antisense Therapeutics Ltd. | Combination therapy |
CN105229035A (zh) * | 2013-03-11 | 2016-01-06 | 诺和诺德保健股份有限公司 | 生长激素化合物 |
EP3303380B1 (de) | 2015-06-02 | 2020-01-15 | Novo Nordisk A/S | Insuline mit polaren rekombinanten erweiterungen |
MA43348A (fr) | 2015-10-01 | 2018-08-08 | Novo Nordisk As | Conjugués de protéines |
EP3606560A2 (de) | 2017-04-05 | 2020-02-12 | Novo Nordisk A/S | Oligomererweiterte insulin-fc-konjugate |
WO2020014307A1 (en) * | 2018-07-11 | 2020-01-16 | Ohio University | Peptide-based inhibitors of growth hormone action and methods of the thereof |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5534617A (en) * | 1988-10-28 | 1996-07-09 | Genentech, Inc. | Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
US5958879A (en) * | 1989-10-12 | 1999-09-28 | Ohio University/Edison Biotechnology Institute | Growth hormone receptor antagonists and methods of reducing growth hormone activity in a mammal |
NZ260103A (en) * | 1990-11-30 | 1996-10-28 | Bio Technology General Corp | Somatotropin with alterations in the alpha-helix-1 region |
ATE196548T1 (de) * | 1991-05-10 | 2000-10-15 | Genentech Inc | Auswählen von agonisten und antagonisten von liganden |
IT1251895B (it) * | 1991-09-27 | 1995-05-26 | Eniricerche Spa | Mutanti dell'ormone della crescita umano e loro impiego |
US5686268A (en) * | 1992-06-19 | 1997-11-11 | Pfizer Inc. | Fused proteins |
DK1568772T3 (da) * | 1995-09-21 | 2010-10-18 | Genentech Inc | Varianter af humant væksthormon |
GB9526733D0 (en) * | 1995-12-30 | 1996-02-28 | Delta Biotechnology Ltd | Fusion proteins |
CA2197408A1 (en) * | 1996-02-13 | 1997-08-14 | Kazuo Chihara | Mutant human growth hormones and their uses |
ATE199570T1 (de) | 1996-08-16 | 2001-03-15 | Medical Res Council | Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln |
IL122818A0 (en) * | 1997-07-10 | 1998-08-16 | Yeda Res & Dev | Chimeric interleukin-6 soluble receptor/ligand protein analogs thereof and uses thereof |
CA2359345A1 (en) * | 1999-01-14 | 2000-07-20 | Bolder Biotechnology, Inc. | Methods for making proteins containing free cysteine residues |
AU2001274234A1 (en) * | 2000-06-16 | 2001-12-24 | Asterion Limited | Binding agents: chimeric ligand/receptor proteins |
GB2389115B (en) * | 2001-12-14 | 2005-03-16 | Asterion Ltd | Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone |
-
2001
- 2001-12-14 GB GB0320479A patent/GB2389115B/en not_active Expired - Fee Related
- 2001-12-14 GB GB0130052A patent/GB2384001B/en not_active Expired - Fee Related
-
2002
- 2002-12-06 CA CA002468439A patent/CA2468439A1/en not_active Abandoned
- 2002-12-06 AT AT02806858T patent/ATE541935T1/de active
- 2002-12-06 PL PL371313A patent/PL210714B1/pl not_active IP Right Cessation
- 2002-12-06 CN CN200910164026A patent/CN101638437A/zh active Pending
- 2002-12-06 AU AU2002366325A patent/AU2002366325B2/en not_active Ceased
- 2002-12-06 US US10/498,497 patent/US7524649B2/en not_active Expired - Fee Related
- 2002-12-06 IL IL16243302A patent/IL162433A0/xx active IP Right Grant
- 2002-12-06 WO PCT/GB2002/005523 patent/WO2003070765A2/en active Application Filing
- 2002-12-06 EP EP10009271A patent/EP2365085A1/de not_active Withdrawn
- 2002-12-06 RU RU2004117777/13A patent/RU2346047C2/ru not_active IP Right Cessation
- 2002-12-06 KR KR1020077021636A patent/KR100879553B1/ko not_active IP Right Cessation
- 2002-12-06 SG SG200705155-0A patent/SG160205A1/en unknown
- 2002-12-06 NZ NZ533550A patent/NZ533550A/en not_active IP Right Cessation
- 2002-12-06 ES ES02806858T patent/ES2378424T3/es not_active Expired - Lifetime
- 2002-12-06 KR KR1020067016929A patent/KR100848802B1/ko not_active IP Right Cessation
- 2002-12-06 HU HU0402496A patent/HUP0402496A3/hu unknown
- 2002-12-06 KR KR10-2004-7009055A patent/KR20040083470A/ko not_active Application Discontinuation
- 2002-12-06 MX MXPA04005675A patent/MXPA04005675A/es active IP Right Grant
- 2002-12-06 EP EP02806858A patent/EP1456385B1/de not_active Expired - Lifetime
- 2002-12-06 JP JP2003569672A patent/JP5248734B2/ja not_active Expired - Fee Related
- 2002-12-06 CN CNB028247817A patent/CN100558899C/zh not_active Expired - Fee Related
-
2004
- 2004-06-07 ZA ZA200404488A patent/ZA200404488B/xx unknown
- 2004-06-10 IL IL162433A patent/IL162433A/en not_active IP Right Cessation
-
2005
- 2005-01-28 HK HK05100765.8A patent/HK1070669A1/xx not_active IP Right Cessation
-
2006
- 2006-01-06 ZA ZA200600149A patent/ZA200600149B/xx unknown
-
2008
- 2008-05-08 RU RU2008118104/13A patent/RU2008118104A/ru not_active Application Discontinuation
-
2009
- 2009-02-19 US US12/389,022 patent/US20090239801A1/en not_active Abandoned
- 2009-09-01 IL IL200659A patent/IL200659A0/en unknown
- 2009-09-28 JP JP2009223065A patent/JP2010043100A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1070669A1 (en) | Growth hormone fusion protein | |
WO2000018932A3 (en) | Receptor based antagonists and methods of making and using | |
IL222149B (en) | A protein comprising a modified version of the fc region of a human antibody with increased binding affinity to fcrn | |
PL336306A1 (en) | Proteinous fusions of tgf-beta ii type receptor with a constant immunoglobulin area | |
HK1144684A1 (en) | Igf-1 fusion polypeptides and therapeutic uses thereof igf-1 | |
IL166750A0 (en) | Modified transferrin fusion proteins | |
DK1129186T3 (da) | Et faktor VIII-polypeptid med faktor VIII:C-aktivitet | |
HK1044966A1 (zh) | C端蛋白標籤 | |
ZA200308589B (en) | Recombinant fusion proteins and the trimers thereof. | |
IL166343A0 (en) | Igg fc/hiv-gp 120/c3d fusion protein | |
AU2002250049A8 (en) | Algorithmic design of peptides for binding and/or modulation of the functions of receptors and/or other proteins | |
EP1539809A4 (de) | Hcv-fusionsproteine mit modifizierten ns3-domänen | |
EP1181052A4 (de) | Bindungsdomänen, basierend auf protein a, mit gewünschten eigenschaften | |
MXPA01003868A (es) | Apomixis conferida por la expresion de proteinas que interactuan con la cinasa receptora de embriogenesis somatica. | |
HK1044956A1 (zh) | 重組細胞聚變份子 | |
EP0999848A4 (de) | Chimäre proteine zur behandlung von diabetes | |
AU3087599A (en) | Human appetite control by glucagon-like peptide receptor binding compounds | |
GB9819998D0 (en) | Immunoglobulin binding protein | |
DE69927375D1 (de) | Fusionsprotein mit direkter verknüpfung des il-6-rezeptors mit il-6 | |
GB9818124D0 (en) | CD28 binding protein | |
AU8149001A (en) | A novel polypeptide, a human TNFR/NGFR protein containing cytochrome C domain and the ploynucleotide encoding the polypeptide | |
GB9909578D0 (en) | Immunoglobulin binding protein | |
NZ501161A (en) | Chimeric human trkA-IgG polypeptides which bind to human nerve growth factor. | |
AU4405201A (en) | A novel polypeptide-human protein 17 containing chromo domain and the polynucleotide encoding said polypeptide | |
DE60019112D1 (de) | Pektat lyase-fusion zur expression und ausscheidung von polypeptiden |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20151206 |